Digoxin prescribing for heart failure in elderly residents of long-term care facilities

Canadian Journal of Cardiology

Volumn 21, Issue 3, 2005, Pages 281-286

  Misiaszek, Brian ^a   Heckman, George A ^a   Merali, Fatima ^a   Turpie, Irene D ^a   Patterson, Christopher J ^a   Flett, Norman ^b   McKelvie, Robert S ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b St Joseph's Villa   (Canada)

^c HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

Aging; Congestive heart failure; Digoxin; Drug toxicity

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CIMETIDINE; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; MACROLIDE; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; QUINIDINE; SPIRONOLACTONE; THYROTROPIN; VASODILATOR AGENT; VERAPAMIL;

AGE DISTRIBUTION; AGED; ANTICOAGULANT THERAPY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG USE; ELDERLY CARE; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; PRESCRIPTION; PREVALENCE; RESIDENTIAL CARE; RISK ASSESSMENT; SIDE EFFECT; THYROTROPIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOTONIC AGENTS; CROSS-SECTIONAL STUDIES; DIGOXIN; DRUG MONITORING; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; FRAIL ELDERLY; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NURSING HOMES; ONTARIO; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; PREVALENCE; RISK FACTORS;

EID: 17444381185     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Flather M, Yusuf S, Kober L, et al; ACE-Inhibitor Myocardial Infarction Collaborative Group. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic review of data from individual patients. Lancet 2000;355:1575-81.
2. Pfeffer MA, Swedberg K, Granger CB, et al, for the CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme. Lancet 2003;362:759-66.
3. Packer M, Coats AJ, Fowler MB, et al, for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
4. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999;353:9-13.
5. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
6. Pitt B, Zannad, F, Remme WJ, et al, for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
7. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
8. Arling ML. Management of heart failure in nursing facility residents according to AMDA guidelines. Nurs Home Med 1997;5:374-80.
9. Forman DE, Chander RB, Lapane KL, Shah P, Stoukides J. Evaluating the use of angiotensin-converting enzyme inhibitors for older nursing home residents with chronic heart failure. J Am Geriatr Soc 1998;46:1550-4.
10. Ranz TT, Blumenschein K, Clifton GD. Prevalence and treatment of heart failure in elderly long-term-care patients. Am J Health Syst Pharm 1999;56:1334-8.
11. Gambassi G, Forman DE, Lapane KL, et al, for the SAGE Study Group. Management of heart failure among very old persons living in long-term care: Has the voice of trials spread? Am Heart J 2000;139:85-93.
12. Ruths S, Straand J, Nygaard HA, Hodneland F. Drug treatment of heart failure - do nursing-home patients deserve better? Scand J Prim Health Care 2000;18:226-31.
13. Forman DE, Coletta D, Kenny D, et al. Clinical issues related to discontinuing digoxin therapy in elderly nursing home patients. Arch Intern Med 1991;151:2194-8.
14. Aronow WS. Prevalence of appropriate and inappropriate indications for use of digoxin in older patients at the time of admission to a nursing home. J Am Geriatr Soc 1996;44:588-90.
15. Gambassi G, Lapane KL, Sgadari A, et al, for the Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. Arch Intern Med 2000;160:53-60.
16. Hanratty CG, McGlinchey P, Johnston GD, Passmore AP. Differential pharmacokinetics of digoxin in elderly patients. Drugs Aging 2000;17:353-62.
17. Weedle PB, Poston JW, Parish PA. The use of digoxin in 55 residential homes for elderly people. Postgrad Med J 1988;64:292-6.
18. Magnani B, Malini PL. Cardiac glycosides. Drug interactions of clinical significance. Drug Safety 1995;12:97-109.
19. Cooper JW. Adverse drug reaction-related hospitalizations of nursing facility patients: A 4-year study. South Med J 1999;92:485-90.
20. Pahor M, Guralnik JM, Gambassi G, Bernabei R, Carosella L, Carbonin P, for the Gruppo Italiano di Farmacovigilanza nell'Anziano. The impact of age on risk of adverse drug reactions to digoxin. J Clin Epidemiol 1993;46:1305-14.
21. Miura T, Kojima R, Sugiura Y, Mizutani M, Takatsu F, Suzuki Y. Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 2000;34:427-32.
22. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003;289:871-8.
23. Carter BL, Small RE, Garnett WR. Monitoring digoxin therapy in two long-term care facilities. J Am Geriatr Soc 1981;29:263-8.
24. Heckman GA, Misiaszek B, Merali F, et al. Management of heart failure in Canadian long-term care facilities. Can J Cardiol 2004;20:963-9.
25. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
26. Wang L, van Belle G, Kukull WB, Larson EB. Predictors of functional change: A longitudinal study of nondemented people aged 65 and older. J Am Geriatr Soc 2002;50:1525-34.
27. Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-86.
28. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
29. Ontario Drug Therapy Guidelines for Congestive Heart Failure in Primary Care, Ontario Program for Optimal Therapeutics. Toronto: Queen's Printer of Ontario, 2000.
30. Aronoff E, ed. Drug Prescribing in Renal Failure, 4th edn. Philadelphia: American College of Physicians, 1999.
31. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med 2001;345:260-5.
32. Dubois D, Dubois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-71.
33. Jelliffe RW, Buell J, Kataba R. Reduction of digitalis toxicity by computer-assisted glycoside dosage regimens. Ann Intern Med 1972;77:891-906.
34. Jelliffe RW, Brooker G. A nomogram for digoxin therapy. Am J Med 1974;57:63-8.
35. Tsujimoto G, Sasaki T, Ishizaki T, Suganama T, Hirayama H. Re-examination of digoxin dosage regimen: Comparison of the proposed nonograms or formulae in elderly patients. Br J Clin Pharmacol 1982;13:493-500.
36. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002;162:1682-8.
37. Arling ML. Outcomes of ACE inhibitor use in nursing facility residents with congestive heart failure. Ann Long Term Care 1998;6:237-41.
38. Ahmed A, Weaver MT, Allman RM, DeLong JF, Aronow WS. Quality of care of nursing home residents hospitalized with heart failure. J Am Geriatr Soc 2002;50:1831-6.
39. Product monograph for Lanoxin, GlaxoSmithKline. Compendium of Pharmaceuticals and Specialties (CPS): The Canadian Durg Reference for Health Professionals, 38th edn. Ottawa: Canadian Pharmaceutical Association, 2003:864-7.
40. Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB Jr. Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med 1971;284:989-97.
41. Lely AH, van Enter CH. Large-scale digitoxin intoxication. Br Med J 1970;3:737-40.
42. Passmore AP, Johnston GD. Digoxin toxicity in the aged. Characterising and avoiding the problem. Drugs Aging 1991;1:364-79.
43. Cooke DM. The use of central nervous system manifestations in the early detection of digitalis toxicity. Heart Lung 1993;22:477-81.
44. Jarrett PG, Rockwood K, Carver D, Stolee P, Cosway S. Illness presentation in elderly patients. Arch Intern Med 1995;155:1060-4.
45. Canadian Study on Health and Aging Study Group. Canadian study on health and aging: Study methods and prevalence of dementia. CMAJ 1994;150:899-913.
46. NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA 1992;268:1018-24.
47. Mitchell SL, Kiely DK, Kiel DP, Lipsitz LA. The epidemiology, clinical characteristics and natural history of older nursing home residents with a diagnosis of Parkinson's disease. J Am Geriatr Soc 1996;44:394-9.
48. Naafs MAB, van der Hoek C, van Duin S, Koorevaar G, Schopman W, Silberbusch J. Decreased renal clearance of digoxin in chronic congestive heart failure. Eur J Clin Pharmacol 1985;28:249-52.
49. Statton ML, Irani WN, Hall SA, et al. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol 1997;29:1206-13.
50. Ware JA, Snow E, Luchi JM, Luchi RJ. Effect of digoxin on ejection fraction in elderly patients with congestive heart failure. J Am Geriatr Soc 1984;32:631-5.
51. Adams KF Jr, Gheorghiade M, Uretsky BF, Patterson JH, Schwartz TA, Young JB. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol 2002;39:946-53